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Background: Extreme exercise may alter the innate immune system. Glycans are involved in several biological
processes including immune system regulation. However, limited data regarding the impact of glycan
supplementation on immunological parameters after strenuous exercise are available. We aimed to determine the
impact of a standardized polysaccharide-based multi-ingredient supplement, Advanced Ambrotose© complex
powder (AA) on salivary secretory Immunoglobulin A (sIgA) and pro- and anti-inflammatory protein levels before
and after a marathon in non-elite runners.
Methods: Forty-one male marathon runners who completed the 42.195 km of the 2016 Barcelona marathon were
randomly assigned to two study groups. Of them, n = 20 (48%) received the AA supplement for 15 days prior the
race (AA group) and n = 21 (52%) did not receive any AA supplement (non-AA group). Saliva and blood samples
were collected the day before the marathon and two days after the end of the race. Salivary IgA, pro-inflammatory
chemokines (Gro-alpha, Gro-beta, MCP-1) and anti-inflammatory proteins (Angiogenin, ACRP, Siglec 5) were
determined using commercially ELISA kits in saliva supernatant. Biochemical parameters, including C-reactive
protein, cardiac biomarkers, and blood hemogram were also evaluated.
Results: Marathon runners who did not receive the AA supplement experienced a decrease of salivary sIgA and
pro-inflammatory chemokines (Gro-alpha and Gro-beta) after the race, while runners with AA supplementation
showed lower levels of anti-inflammatory chemokines (Angiogenin). Gro-alpha and Gro-beta salivary levels were
lower before the race in the AA group and correlated with blood leukocytes and platelets.
Conclusions: Changes in salivary sIgA and inflammatory chemokines, especially Gro-alfa and Gro-beta, were
observed in marathon runners supplemented with AA prior to the race. These findings suggested that AA may
have a positive effect on immune response after a strenuous exercise.
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In recent years, there has been a significant increase of
participants in ultra-endurance races such as marathons
and ultramarathons. In the United States alone, mara-
thon runners have increased from 25,000 in 1976 to al-
most 503,000 in 2010 [18]. Competing in very strenuous
events imposes severe metabolic stress and causes acute
responses that may negatively alter the immune system
[17]. A high level of physical demand during such events
induces a wide range of metabolic changes and causes
micro-injuries in the muscles and other tissues. This
physical demand increases the migration of white blood
cells to the sites of injury, and induces acute phase in-
flammatory reactions [5, 16, 28]. The local response to
tissue injury involves the production of a large number
of acute phase proteins and cytokines related to innate
immunity such as secretory Immunoglobulin A (sIgA)
or inflammatory chemokines [9, 30]. Secretory Immuno-
globulin A (sIgA) is a first line of defense against exter-
nal agents, serving as a noninvasive biomarker of
mucosal immunity [10]. Several studies have shown
significant sIgA changes following strenuous exercise
[3, 19, 24]. Other important immune factors present
in mucosal secretion also change after prolonged running
[6, 20, 24]. These changes include: pro-inflammatory che-
mokines, such as Gro-alpha (neutrophil-activating protein
3 and melanoma growth stimulating activity), Gro-beta
(macrophage inflammatory protein, secreted by mono-
cytes and macrophages and chemotactic for polymorpho-
nuclear leukocytes and hematopoietic stem cells) and
MCP-1 (to recruit monocytes, memory T cells, and den-
dritic cells to the sites of inflammation produced by either
tissue injury or infection); anti-inflammatory proteins such
as Angiogenin (associated with altered normality through
angiogenesis and through activating gene expression that
suppresses apoptosis), Adipokine ACRP30 (cell signaling
protein secreted by adipose tissue involved in regulating
glucose levels as well as fatty acid breakdown) and Siglec5
(Sialic acid-binding Ig-like lectin 5).
Glycans (a generic term for any sugar or assembly of
sugars, in free form or attached to another molecule) are
directly involved in physiology [31]. Glycans are involved
in inflammation and immune system activation [11]. A
standardized polysaccharide-based multi-ingredient sup-
plement including glycans (Advanced Ambrotose© com-
plex powder (AA)) may produce a significant overall
shift towards an increased sialylation of serum glycopro-
teins. Sialylation changes can have a key role in many as-
pects of the immune response [2]. It is therefore not
surprising that one of the physiological effects of these
polysaccharides is the immunomodulation through the
glycosylation of proteins [15]. AA is a saccharide supple-
ment containing a standardized combination of plant
polysaccharides (a source of mannose, galactose, fucose,xylose, glucose, n-acetyl-glucosamine, n-acetyl-neuraminic
acid, and n-acetyl-galactosamine) that may regulate im-
munity. In controlled human trials, polysaccharide intake
enhanced the immune system biomarkers in the blood of
healthy adults [22]. The effect of dietary supplements with
polysaccharides on retired professional football players
supported and optimized their quality of life [25]. How-
ever, no data regarding the impact of AA supplementation
on healthy marathon runners performing strenuous phys-
ical activity is available.
Our hypothesis is that glycan supplementations before
strenuous physical activity enhances immune function
and balances pro-inflammatory and anti-inflammatory
proteins. Therefore, the aim of this study is to determine
the impact of AA in the levels of sIgA, pro-inflammatory
chemokines and anti-inflammatory proteins before and
after running a marathon in non-elite marathoners.
Methods
Participants
This study is a part of the SUMMIT project (Health in
Ultra-Marathons and their Limits), whose objective is to
evaluate the behavior of certain clinical parameters in
different races and was approved by an institutional re-
view board (IIBSP-SUMMIT-2016-02). In this study, 41
male non-elite runners of the Barcelona Marathon 2016
participated and they gave signed informed consent.
All runners were weighed on race morning within 2 h
of race start in racing attire with running shoes and im-
mediately after completing the race using the same scale
Jata 565 model. Later the body mass index (BMI) was
calculated using the formula BMI = weight (kg) / height
(m2). The mean age was 39.3 ± 9.2 years old.
Study groups
Twenty participants (48%) received AA supplementation
prior to the race (AA group), while 21 participants (52%)
did not receive the AA supplement prior to the race
(non-AA group). AA was administrated at dose of 8 g/
day (with Arabinolactan, Aloe Vera extract, rice starch,
ghatti gum, gum Tragacanth, Glucosamine HCl, Wak-
ame algae extract) for 15 days before the marathon. The
41 athletes were selected for being homogeneous in age,
weekly training hours, years of training, weight and
height (Table 1), and were randomly assigned into the
two study groups.
Saliva and blood collection
Saliva samples were collected 48 h before the marathon
(d0 samples) and two days after the end of the race (d2
samples). Saliva was collected into clean, sterile tubes,
maintained at 4 °C before centrifugation at 9500×g 10
min at 4 °C. Supernatant was aspirated and 3 different
aliquots were frozen at − 20 °C, until evaluated.
Table 1 Participant characteristics, anthropometric and training data before the marathon
Baseline characteristics Total cohort Non-AA group AA group p-value
Number of runners 41 21 20
Age (years) 39.3 ± 9.2 39.3 ± 12.8 39.2 ± 4.9 0.717
Weight (Kg) 77.0 ± 11.0 74.0 ± 12.0 78.5 ± 12.0 0.208
Height (cm) 178.0 ± 8.0 178.0 ± 7.0 179.5 ± 8.0 0.142
BMI (kg/m2) 24.1 ± 3.4 23.8 ± 3.0 24.2 ± 3.7 0.696
Training (years) 8.0 ± 8.5 7.0 ± 6.5 9.0 ± 12.3 0.537
Training (hours/week) 7.0 ± 5.3 6.0 ± 4.5 7.0 ± 4.9 0.106
Loss weight (%) 3.1 ± 1.8 3.1 ± 2.9 3.1 ± 1.7 0.276
Race time 3.5 ± 0.5 3.4 ± 0.6 3.6 ± 0.5 0.265
AA group: Participants received Advanced Ambrotose Complex Powder (AA) supplementation prior the race
Non-AA group: Participants did not received any AA supplement prior the race
BMI: body mass index
Values are reported as mean ± SD for the quantitative and in percentage for the categorical. ANOVA test was used for parametric variables; Kruskal Wallis test was
used for non parametric variables; Chi-Square Pearson for categorical variables
Roca et al. Journal of the International Society of Sports Nutrition           (2019) 16:14 Page 3 of 8Three 10mL blood samples were obtained from the
antecubital vein 48 h before the marathon (d0 samples), at
completion (d1 samples), and 48 h after the race (d2 sam-
ples). After the marathon, samples (d1) and weights were
obtained within the 10min interval after completing the
race and before drinking any fluid or emptying the bladder.
Saliva analysis
Saliva samples were thawed and total saliva protein was
quantified using Qubit protein Assay Kit (molecular
probes Life Technologies). Salivary IgA (Human IgA,
Platinum ELISA, ebioscience, Affymetrix, Santa Clare,
CA), Lactoferrin, Lysozyme (AssayPro, St, Charles, MO,
USA), Gro-alpha/CXCL1, Gro-beta/CXCL2 and MCP-1
(Elabscience, Houston, Texas) were measured by ELISA
according to manufacturer’s instructions. Limits of detec-
tion were for IgA: 1.6 ng/ml; lactoferrin: 0.625 ng/ml; lyso-
zyme: 0.0781 ng/ml; Gro-alpha/CXCL1: 15.63 pg/ml,
Gro-beta/CXCL2: 15.63 pg/ml, MCP-1: 15.63 pg/ml,
Angiogenin: 1.64 pg/ml, ARCP30: 24.69 pg/ml and Siglec
5: 6.86 pg/ml. The data was expressed as concentration of
each protein relative to total saliva protein concentration.
Blood analysis
The complete blood counts were performed on the Uni-
cel DxH800 automated hematology analyzer (Beckman
Coulter, Miami, FL, USA). N-terminal pro-B-type natri-
uretic peptide (NT-proBNP) was quantified in whole
EDTA blood using the AQT90 FLEX immunoassay
(Radiometer Medical, Copenhagen, Denmark). Serum
creatine kinase (CK) and C-reactive protein (CRP) were
determined using the AU-5800 Chemistry Analyzer
(Beckman Coulter). Troponin T was measured from
serum, using a High Sensitive Troponin-T assay in a
Cobas e601 platform (Roche Diagnostics, Barcelona,
Spain). ST2 was measured from serum samples using a
high-sensitivity sandwich monoclonal immunoassay(Pressage® ST2 assay, Critical Diagnostics, San Diego,
CA, USA).
Statistical analysis
The Kolmogorov-Smirnov test was applied to test the nor-
mal distribution of the data. All variables, with a normal
distribution, were reported as mean ± standard deviation
(SD). The rest of the variables were reported as median
(interquartile rank) (IQR). T-test and paired t-test were re-
spectively used for the comparison of independent and re-
lated variables with normal distribution. Wilcoxon test
was used for the comparison of related variables with
non-normally distributed data. Pearson’s and Spearman’s
coefficients were respectively used to correlate changes
between normal and between non-normal distributed var-
iables. ANOVA and Kruskal-Wallis test were respectively
used for comparative analyses of multiple normal and
non-normal distributed data. Chi-square tests were used




Forty-one male non-elite marathon runners completed
the 42.195 km of the 2016 Barcelona Marathon. Mean
finishing time was 3 h and 28min ± 0. 41 h. Median
(interquartile range) age was 39 ± 9 years old, with a
weight of 77 ± 11 kg, height of 178 ± 8 cm and Body
Mass Index (BMI) of 24.1 ± 3.4. Median training years
were 8 ± 8, with a median of 7 ± 5 h per week.
No significant differences in age, weight, height, and
training were found between runners who received AA
supplementation and those who did not (Table 1).
Plasma and blood measurements
C-reactive protein increased significantly 48 h after the
marathon (d2), although no significant differences
Roca et al. Journal of the International Society of Sports Nutrition           (2019) 16:14 Page 4 of 8between AA and non-AA groups were found. Similarly,
all evaluated cardiac (Hs-TnT, St2 and NTproBNP) and
muscle damage (CK) biomarkers increased after the
race, but no significant differences between participants
in either group were found (Table 2).
Hemoglobin, hematocrit, erythrocytes and platelets
counts did not change after the race (d1), with no differ-
ences between groups. However, a marked increase in
leukocyte counts per L was found in both groups after the
race (d1) and participants who received AA supplementa-
tion for 15 days prior to the race experienced a lower in-
crease compared to those without the AATable 2 Plasma and blood measurements before, after and 48 h aft
Biochemical values Total cohort
CRP_d0 (mg/dL) 0.85 ± 1.18
CRP_d1 (mg/dL) 0.55 ± 0.85
CRP_d2 (mg/dL) 7.6 ± 4.65
CK_d0 (U/L) 170.5 ± 123.8
CK_d1 (U/L) 566.0 ± 282.3
CK_d2 (U/L) 764.5 ± 540.8
Hs-TnT_d0 (ng/L) 3.1 ± 2.7
Hs-TnT_d1 (ng/L) 49.6 ± 68.1
Hs-TnT_d2 (ng/L) 4.8 ± 6.3
St2_d0 (ng/mL) 34.0 ± 14.8
St2_d1 (ng/mL) 54.9 ± 30.3
St2_d2 (ng/mL) 32.9 ± 20.5
NTproBNP_d0 (ng/L) 70.0 ± 0
NTproBNP_d1 (ng/L) 94.5 ± 70.5
NTproBNP_d2 (ng/L) 70.0 ± 0
Hemoglobin_d0 (g/L) 14.8 ± 1.3
Hemoglobin_d1 (g/L) 14.7 ± 1.1
Hemoglobin_d2 (g/L) 14.3 ± 0.7
Hematocrit_d0 43.7 ± 3.0
Hematocrit_d1 44.0 ± 4.2
Hematocrit_d2 42.7 ± 2.2
Erythrocytes_d0 (10Exp12/L) 4.9 ± 0.6
Erythrocytes_d1 (10Exp12/L) 5.0 ± 0.5
Erythrocytes_d2 (10Exp12/L) 4.8 ± 0.4
Platelets_d0 (10Exp9/L) 0.2 ± 0.0
Platelets_d1 (10Exp9/L) 0.2 ± 0.0
Platelets_d2 (10Exp9/L) 0.2 ± 0.0
Leukocyte_d0 (109/L) 6.5 ± 1.9
Leukocyte_d1 (109/L) 12.2 ± 5.3
Leukocyte_d2 (109/L) 6.6 ± 1.3
AA group: Participants received Advanced Ambrotose Complex Powder (AA) supple
Non-AA group: Participants did not received any AA supplement prior the race
CK creatine kinase, CRP C-reactive protein, HGB hemoglobin, Hs-TnT high-sensitivity
Values are reported as mean ± SD for the quantitative and in percentage for the ca
was used for non parametric variables; Chi-Square Pearson for categorical variablessupplementation (13.2 ± 4.6 vs 16.1 ± 4.4 × 109/L, p = 0.03)
(Table 2).Salivary IgA
No differences in salivary IgA levels normalized to total
salivary protein before (d0) and 48 h after the race (d2)
were found (0.47 ± 0.44 vs 0.37 ± 0.29, p = 0.6). How-
ever, when participants with and without AA supple-
mentation were compared, a decrease of sIgA 48 h after
the race (d2) was observed in the non-AA group (0.55
± 0.37 vs 0.31 ± 0.35, p = 0.01), while no differenceser the marathon in 41 runners
Non-AA group AA group p-value
0.60 ± 1.28 1.00 ± 1.23 0.683
0.45 ± 2.91 0.95 ± 2.48 0.606
6.80 ± 5.00 8.95 ± 4.25 0.359
188.5 ± 172.3 136.0 ± 125.3 0.633
566.0 ± 251.5 567.5 ± 396.3 0.958
788.5 ± 787.8 650.0 ± 513.8 0.368
2.9 ± 2.0 3.4 ± 5.0 0.407
48.9 ± 68.8 49.9 ± 68.8 0.449
4.9 ± 7.2 4.6 ± 3.7 0.334
34.7 ± 16.2 28.6 ± 16.0 0.394
59.0 ± 40.5 43.3 ± 30.4 0.256
37.7 ± 19.3 29.4 ± 17.1 0.059
70.0 ± 0 70.0 ± 0 0.336
100.5 ± 50.3 85.5 ± 221.3 0.392
70.0 ± 0 70.0 ± 0.5 0.845
14.8 ± 1.1 14.7 ± 1.6 0.350
14.8 ± 1.0 14.5 ± 0.3 0.173
14.4 ± 0.7 14.2 ± 0.9 0.170
43.7 ± 3.1 43.8 ± 3.1 0.327
44.3 ± 3.2 43.3 ± 3.4 0.132
42.8 ± 1.8 42.2 ± 3.7 0.114
4.9 ± 0.4 5.1 ± 0.7 0.903
5.0 ± 0.4 5.0 ± 0.8 0.586
4.8 ± 0.3 4.9 ± 0.5 0.532
0.2 ± 0.0 0.2 ± 0.0 0.063
0.2 ± 0.1 0.2 ± 0.0 0.852
0.2 ± 0.0 0.2 ± 0.0 0.555
6.4 ± 1.3 6.5 ± 3.2 0.860
16.1 ± 4.4 13.2 ± 4.6 0.032
6.6 ± 1.4 6.6 ± 1.8 0.217
mentation prior the race
troponin T, NT-proBNP N-terminal pro-B-type natriuretic peptide
tegorical. ANOVA test was used for parametric variables; Kruskal Wallis test
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were found (0.25 ± 0.33 vs 0.24 ± 0.32, p = 0.5) (Fig. 1).
Salivary pro inflammatory proteins
A decrease of pro-inflammatory salivary proteins such
as Gro-alfa, Gro-beta and MCP-1 after the race was
observed in all participants, although differences were
not statistically significant (data not shown). Neverthe-
less, the decline in Gro-alpha (Fig. 2a) and Gro-beta
(Fig. 2b) was statistically significant in those runners who
did not receive the AA supplement (0.38 ± 0.20 vs
0.24 ± 0.18, p = 0.02 and 0.47 ± 0.26 vs 0.32 ± 0.26, p =
0.03), while differences were not observed in the AA
group. Furthermore, basal levels of Gro-alpha and
Gro-beta were significantly lower (p = 0.03) in the AA
group at baseline before the marathon (d0) compared
to the non-AA group (Fig. 2).
Salivary anti-inflammatory proteins
No statistically significant differences of salivary
anti-inflammatory proteins such as ACRP, angiotensin,
and Siglec 5 were observed before (d0) and 48 h after
the marathon (d2) (data not shown). However, in those
runners of the AA group, a significant decrease of
Angiogenin 48 h after the race (d2) was observed (0.18
± 0.08 vs 0.14 ± 0.07, p = 0.04), while differences were
not observed in the non-AA group (0.3 ± 0.13 vs 0.17 ±
0.10, p = 0.7) (Fig. 3).
Systemic correlations
After the race, those runners who received the AA supple-
ment (AA group) showed positive correlations be-
tween salivary Gro-alpha levels with leukocyte counts per
L (r = 0.38, p = 0.02) and a tendency between Gro-beta sal-
ivary levels and blood platelet counts (r = 0.27, p = 0.06).Fig. 1 Salivary IgA levels before (d0) and 48 h after the marathon
(d2) between groupsThese systemic correlations were not observed in the
non-AA group (Fig. 4).
Discussion
In our study, we demonstrated significant changes in sal-
ivary biomarkers of immune function in healthy,
non-elite athletes before and after a strenuous exercise
like an asphalt marathon, after consuming a
polysaccharide-based multi-ingredient supplement, AA,
for 15 days prior to exercise. Specifically, a decrease in
salivary sIgA, Gro-alfa and Gro-beta were observed after
the marathon in those runners who did not receive AA
supplement prior the race, while those runners who re-
ceived the AA supplement showed a decrease in a saliv-
ary Angiogenin. Gro-alpha and Gro-beta salivary levels
were lower before the race in the AA group and corre-
lated with the counts of blood leukocytes and platelets.
These findings suggest that AA supplementation pro-
duces changes in salivary immunity that may have a
positive effect on immunity before and after a marathon.
sIgA is a key component of innate immunity and pro-
vides a first line of defense against pathogens at mucosal
surfaces [8]. Numerous studies have assessed the saliva
sIgA response to prolonged strenuous exercise to ex-
plore whether immunity may be temporarily compro-
mised after the exercise. Most of the studies described a
post-exercise decrease in sIgA, including Nordic skiers
after a 50 km race [29] or trained cyclists cycling for
more than 2 h on a stationary ergometer [32]. In mara-
thon runners, a significant decrease of sIgA following a
marathon race has been described [19], which was inde-
pendent of gender, age or carbohydrate ingestion. In our
study, runners with AA supplementation did not experi-
ence a significant decrease in sIgA after the marathon,
which was observed in runners without the AA. These
findings suggested that AA supplement enhanced immun-
ity by avoiding the sIgA decrease after the race. Different
studies have postulated that glycosylation plays an import-
ant role in the biosynthesis and biological activity of the
proteins involved in antigen recognition, such as sIgA
[23]. Further studies are needed to explore this pathway,
which may be crucial in order to better understand the ef-
fect of strenuous exercise on mucosal immunity.
Supplementation with glycans can also result in salivary
glycol-modifications of proteins. These modifications can
regulate the synthesis and/or degradation of pro- and
anti-inflammatory molecules participating in the immune
response of runners to strenuous effort. Several inflamma-
tory chemokines have demonstrated a potential role in the
regulation of immune response during exercise [27]. In
our study, we demonstrated that Gro-alfa and Gro-beta,
two pro-inflammatory chemokines, involved in the attrac-
tion of neutrophils to the site of inflammation, decreased
in saliva after the race in those runners who did not
Fig. 2 Salivary pro inflammatory proteins, gro alpha (a) and gro beta (b) before (d0) and 48 h after the marathon (d2) between groups
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suppressed Gro-alfa [4] and, in experimental models, exer-
cise down-regulates multiple inflammatory cytokines [26],
including Gro-alfa and Gro-beta, that results in a systemic
anti-inflammatory effect [1, 13]. These findings were not
observed in runners who received the AA supplement,
suggesting that they had better immunoregulation. Run-
ners with AA supplementation have also showed a de-
crease in salivary Angiogenin levels, which was not
detected in runners without AA. It suggests that salivary
pro-inflammatory proteins can be buffered with
anti-inflammatory ones, especially those produced by run-
ners supplemented with AA. In addition, it is important to
note that after 15 days on AA, the baseline levels of
Gro-alfa, Gro-beta and Angiogenin were different in run-
ners with and without AA. Interpretations of all these sal-
ivary inflammatory changes are complex and require
further more detailed studies.Fig. 3 Salivary anti-inflammatory protein Angiogenin before (d0)
and 48 h after the marathon (d2) between groupsThe systemic effect of glycans has been described in
several studies [15]. Interestingly, it is postulated that
glycans may regulate leukocyte activity [21]. In our
study, runners who received the AA supplement experi-
enced a lower increase in total blood leukocyte counts
after the race compared to those runners without the
AA supplement. Furthermore, a correlation between sal-
ivary levels of Gro-alpha with blood leukocyte counts
and salivary Gro-beta levels with blood platelet counts
were observed in the AA group. All in all, these findings
suggested a relationship between salivary and systemic
immunity, especially in those runners who received the
AA supplement prior to the race. The association be-
tween high dietary protein during high-intensity training
and reduction in respiratory symptoms in elite cyclists
by restoring impairments in leukocyte trafficking has
also been reported [35] The influence of ingredients
other than glycans on the immune system has been re-
ported. For example, brown seaweed [33], Aloe vera [12]
and glucosamine [14] have antioxidant activity and
anti-inflammatory effects. Arabinogalactan decreases the
incidence of infectious episodes by improving serum-
antigen specific IgG and IgE response to Streptococcus
pneumonia [7]. Starch supplementation promotes the
growth of commensal bacteria that may improve bowel
health [34]. However, more work is needed to clarify the
mechanism that may explain these important results.
Our study has limitations. First, we only have studied
men, and we cannot exclude the effect of glycans in sal-
ivary immunity based on sex. Second, due to the small
sample size of runners included, the results should be
validated in further studies before generalizing them.
Third, runners received the AA supplement for 15 days
prior the race, and the effect of taking this supplement
for a longer time may be different. Fourth, the influence
of ingredients included in the AA supplements which
are not glycans such as glucosamine and Aloe Vera on
Fig. 4 Systemic correlations 48 h after the marathon (d2) between: salivary Gro-alpha levels with leukocyte counts in non-AA group (a) and AA
group (b) and Gro-beta salivary levels and blood platelet counts in non-AA group (c) and AA group (d)
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studies in non-elite marathon runners should be per-
formed to better clarify this important point.Conclusion
In conclusion, our study documented significant changes
in salivary and systemic immunological biomarkers in
marathon runners after consuming a polysaccharide-based
multi-ingredient supplement AA, before and after the race.
Further research using randomized, double-blind,
placebo-controlled design will extend knowledge of the
potential benefits nutritional dietary supplementation with
polysaccharides may have in marathon runners.Abbreviations
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